Shockwave Medical, Inc. Sustainability Profile
Shockwave Medical, Inc., headquartered in the United States, is a pioneering company in the medical device industry, specialising in innovative treatments for cardiovascular diseases. Founded in 2009, Shockwave has made significant strides with its unique intravascular lithotripsy technology, which utilises sonic waves to treat calcified plaque in arteries, enhancing patient outcomes in peripheral and coronary interventions. With a strong presence across major operational regions in North America and Europe, Shockwave Medical has established itself as a leader in the field. The company’s flagship products, including the Shockwave IVL System, are distinguished by their ability to safely and effectively modify calcified lesions, setting new standards in vascular care. Recognised for its commitment to advancing medical technology, Shockwave continues to achieve notable milestones, solidifying its position as a key player in the evolving landscape of cardiovascular treatment.
DitchCarbon Score
How does Shockwave Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shockwave Medical, Inc.'s score of 76 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shockwave Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Johnson & Johnson, and as such, it inherits emissions data and climate commitments from its parent organisation. While no absolute emissions figures are provided, Shockwave Medical is aligned with Johnson & Johnson's sustainability initiatives, which include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative. These commitments reflect a broader industry trend towards reducing carbon footprints and enhancing climate resilience. As a subsidiary, Shockwave Medical's climate strategies are influenced by Johnson & Johnson's overarching goals, which aim for significant reductions in greenhouse gas emissions across all scopes. However, specific reduction targets or achievements for Shockwave Medical have not been disclosed. In summary, while detailed emissions data for Shockwave Medical is not available, the company is part of a corporate family that prioritises climate action and sustainability through established initiatives and commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Shockwave Medical, Inc.'s Industry?
How Carbon Intensive is Shockwave Medical, Inc.'s Location?
Shockwave Medical, Inc.'s Scope 3 Categories Breakdown
Shockwave Medical, Inc.'s Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Shockwave Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shockwave Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
